Kazia Therapeutics Limited
Stock Forecast, Prediction & Price Target

Kazia Therapeutics Limited Financial Estimates

Kazia Therapeutics Limited Revenue Estimates

Kazia Therapeutics Limited EBITDA Estimates

Kazia Therapeutics Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 6/30/2022 6/30/2023 6/30/2024 6/30/2026 6/30/2027
Revenue
 
% change YoY
$25
 
N/A
$555
 
2120%
$2.30M
 
415755.85%
Avg: $2.70M
Low: $2.70M
High: $2.70M
avg. 17.11%
Avg: $24.17M
Low: $24.17M
High: $24.17M
avg. 794.22%
Net Income
 
% change YoY
$-24.64M
 
N/A
$-20.46M
 
16.96%
$-26.77M
 
-30.84%
Avg: $-916.69K
Low: $-916.69K
High: $-916.69K
avg. 96.57%
Avg: $0
Low: $0
High: $0
avg. 100%
EBITDA
 
% change YoY
$-24.74M
 
N/A
$-22.27M
 
9.96%
$-26.76M
 
-20.15%
Avg: $-2.34M
Low: $-2.34M
High: $-2.34M
avg. 91.24%
Avg: $-20.96M
Low: $-20.96M
High: $-20.96M
avg. -794.22%
EPS
 
% change YoY
-$1.86
 
N/A
-$1.12
 
39.78%
$0
 
100%
Avg: -$0.05
Low: -$0.05
High: -$0.05
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 100%
Operating Expenses
 
% change YoY
$24.88M
 
N/A
$24.12M
 
-3.03%
$2.30M
 
-90.43%
Avg: $111.85B
Low: $111.85B
High: $111.85B
avg. 4846254.76%
Avg: $1.00T
Low: $1.00T
High: $1.00T
avg. 794.22%

FAQ

What is Kazia Therapeutics Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 48.28% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is -916.69K, average is -916.69K and high is -916.69K.

What is Kazia Therapeutics Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 405.66% in 2026-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $2.70M, average is $2.70M and high is $2.70M.

What is Kazia Therapeutics Limited stock earnings per share growth forecast?

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.05, average is -$0.05 and high is $-0.04.